AnalysisNews

BOLD today

$2.46+$0.01 (+0.41%)close Nov 11, 2026

Trend

DailyUptrend (starting)

4 hourBullish

1 hourSymmetric Triangle

15 minStrong Bullish

5 minStrong Bullish

Daily trend turns down below $25.41

Key levels

Resistance$13.55

Resistance$13.13

Latest news & SEC filings

SEC FilingBoundless Bio, Inc. filed an insider trading report (Form 4)

All BOLD news →

About Boundless Bio

Boundless Bio is a clinical-stage oncology company developing therapies for oncogene-amplified cancers by targeting extrachromosomal DNA (ecDNA). Its lead candidate, BBI-940, is an oral kinesin degrader in a Phase 1 trial for certain breast cancers, and it also has BBI-355, a CHK1 inhibitor, and BBI-825, an RNR inhibitor. The company uses its Spyglass platform to discover drugs that exploit ecDNA biology and operates in the United States.

Based on the company's 10-K filed Mar 9, 2026.

Nasdaq · Healthcare

Boundless Bio, Inc. (BOLD)

$2.46+0.01 (+0.41%)
HOLDGrade: DRisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
2.382.442.512.572.46Oct 9Oct 19Oct 27Nov 4
High2.46
Low2.39
Open2.46
Volume10K
Avg Vol136K
VWAP2.42
30d High2.64
30d Low2.31
30d Chg-5.02%

What Is the Price Target for BOLD?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $2.46Upside: +0.0%Confidence: 20%Method: No Coverage

Is BOLD a Buy or Sell Right Now?

34
Investability Score
HOLD12-18 months

Thesis

  • •Smart money flows are positive — institutional and insider activity shows net buying.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BOLD.

Start Free Trial →

Is BOLD Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B

Fair Value

$7.51

7

Moat Score

NONE

1/9

Piotroski Score

-2.3

Altman Z-Score

What Is Smart Money Doing with BOLD?

Insider Signal

BUYING

13 buys / 1 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

MEDIUM

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
TANG KEVIN10% ownerBuy249$597.60Nov 10, 2026
TANG KEVIN10% ownerBuy1,700$4KNov 6, 2026
TANG KEVIN10% ownerBuy8,390$20KNov 5, 2026
TANG KEVIN10% ownerBuy517$1KNov 4, 2026
TANG KEVIN10% ownerBuy2,255$5KNov 3, 2026
TANG KEVIN10% ownerBuy10,707$26KOct 27, 2026
TANG KEVIN10% ownerBuy9,606$23KOct 26, 2026
TANG KEVIN10% ownerBuy6,234$15KOct 23, 2026
TANG KEVIN10% ownerBuy5,800$14KOct 22, 2026
TANG KEVIN10% ownerBuy220$521.40Oct 20, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

BOLD Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

32.47%

FCF Growth YoY

25.5%

Revenue Trend

UNKNOWN

Dark Pool Trades for BOLD

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for BOLD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
20:18:40$2.451,100$$3KSELL
15:18:19$2.503,739$$9KBUY
18:38:26$2.462,900$$7KBUY
16:04:26$2.451,000$$2KSELL
15:30:09$2.451,600$$4KBUY

5 dark pool trades shown · $$26K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

What Traders Are Saying About BOLD

4 posts

SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for BOLD. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

N
Nicole AdamsVERIFIED1d ago

Smart Money Moves $TXO — SIMPSON BOB R | Sale $1.2M $EWTX — Nofi Michael | Sale $EWTX — Nofi Michael | Sale $202K $OESX — BRODIN J PER | Sale $26K $BOLD — TANG KEVIN | Sale $1K

41 views
N
Nicole AdamsVERIFIED6d ago

Smart Money Moves $ETRA — GORDON CARL L | Sale $226K $ETRA — GORDON CARL L | Sale $915K $ETRA — ORBIMED ADVISORS LLC | Sale $226K $ETRA — ORBIMED ADVISORS LLC | Sale $915K $BOLD — TANG KEVIN | Sale $...

140 views
N
Nicole AdamsVERIFIED16d ago

Smart Money Moves $LONA — PERCEPTIVE ADVISORS LLC | Sale $1K $BOLD — TANG KEVIN | Sale $23K $PDX — Saba Capital Management, L.P. | Sale $256K $PETV — LOWENTHAL GARRY N | Sale $5K $CURB — Lukes David ...

62 views

Join 3,500+ traders discussing BOLD in real-time

Trade ideas, setups, dark pool alerts, and AI-powered analysis

Join the discussion

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Boundless Bio, Inc. (BOLD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

BOLD — frequently asked questions

What is BOLD stock price today?

Boundless Bio, Inc. (BOLD) is at $2.46, up 0.41% (+$0.01) at the Nov 11, 2026 close.

Why is BOLD stock moving today?

Latest BOLD news — Nov 5, 2026: Boundless Bio, Inc. filed an insider trading report (Form 4)

Did BOLD beat earnings?

BOLD last reported on Aug 10, 2026: EPS -$1.06 vs -$0.61 expected — a miss of 73.8%.

Does BOLD pay a dividend?

BOLD does not currently pay a dividend.

What are BOLD support and resistance levels?

Resistance: $13.13, $13.55, $13.90.

What are insiders doing with BOLD?

Insider activity: BUYING, 13 buys and 1 sells in the last 90 days.

What is the latest news on BOLD?

Nov 5, 2026: Boundless Bio, Inc. filed an insider trading report (Form 4)